220 related articles for article (PubMed ID: 20069572)
1. Tensin 2 modulates cell contractility in 3D collagen gels through the RhoGAP DLC1.
Clark K; Howe JD; Pullar CE; Green JA; Artym VV; Yamada KM; Critchley DR
J Cell Biochem; 2010 Mar; 109(4):808-17. PubMed ID: 20069572
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
Cao X; Voss C; Zhao B; Kaneko T; Li SS
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
[TBL] [Abstract][Full Text] [Related]
3. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
Chan LK; Ko FC; Ng IO; Yam JW
PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
Qian X; Li G; Asmussen HK; Asnaghi L; Vass WC; Braverman R; Yamada KM; Popescu NC; Papageorge AG; Lowy DR
Proc Natl Acad Sci U S A; 2007 May; 104(21):9012-7. PubMed ID: 17517630
[TBL] [Abstract][Full Text] [Related]
5. Dynamics and segregation of cell-matrix adhesions in cultured fibroblasts.
Zamir E; Katz M; Posen Y; Erez N; Yamada KM; Katz BZ; Lin S; Lin DC; Bershadsky A; Kam Z; Geiger B
Nat Cell Biol; 2000 Apr; 2(4):191-6. PubMed ID: 10783236
[TBL] [Abstract][Full Text] [Related]
6. Tensin1 positively regulates RhoA activity through its interaction with DLC1.
Shih YP; Sun P; Wang A; Lo SH
Biochim Biophys Acta; 2015 Dec; 1853(12):3258-65. PubMed ID: 26427649
[TBL] [Abstract][Full Text] [Related]
7. Association of the tensin N-terminal protein-tyrosine phosphatase domain with the alpha isoform of protein phosphatase-1 in focal adhesions.
Eto M; Kirkbride J; Elliott E; Lo SH; Brautigan DL
J Biol Chem; 2007 Jun; 282(24):17806-15. PubMed ID: 17435217
[TBL] [Abstract][Full Text] [Related]
8. Identification of subcellular targeting sequences of Cten reveals its role in cell proliferation.
Hong SY; Shih YP; Lo A; Lo SH
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):450-458. PubMed ID: 30321615
[TBL] [Abstract][Full Text] [Related]
9. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
[TBL] [Abstract][Full Text] [Related]
10. START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2.
Kawai K; Kitamura SY; Maehira K; Seike J; Yagisawa H
Adv Enzyme Regul; 2010; 50(1):202-15. PubMed ID: 19895840
[No Abstract] [Full Text] [Related]
11. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
[TBL] [Abstract][Full Text] [Related]
12. The Abl-related gene tyrosine kinase acts through p190RhoGAP to inhibit actomyosin contractility and regulate focal adhesion dynamics upon adhesion to fibronectin.
Peacock JG; Miller AL; Bradley WD; Rodriguez OC; Webb DJ; Koleske AJ
Mol Biol Cell; 2007 Oct; 18(10):3860-72. PubMed ID: 17652459
[TBL] [Abstract][Full Text] [Related]
13. The molecular and clinical role of Tensin 1/2/3 in cancer.
Mainsiouw L; Ryan ME; Hafizi S; Fleming JC
J Cell Mol Med; 2023 Jul; 27(13):1763-1774. PubMed ID: 37296531
[TBL] [Abstract][Full Text] [Related]
14. The cancer chemopreventive agent resveratrol induces tensin, a cell-matrix adhesion protein with signaling and antitumor activities.
Rodrigue CM; Porteu F; Navarro N; Bruyneel E; Bracke M; Romeo PH; Gespach C; Garel MC
Oncogene; 2005 May; 24(20):3274-84. PubMed ID: 15735708
[TBL] [Abstract][Full Text] [Related]
15. N-cadherin cell-cell adhesion complexes are regulated by fibronectin matrix assembly.
Lefort CT; Wojciechowski K; Hocking DC
J Biol Chem; 2011 Jan; 286(4):3149-60. PubMed ID: 21084302
[TBL] [Abstract][Full Text] [Related]
16. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.
Wong CC; Wong CM; Ko FC; Chan LK; Ching YP; Yam JW; Ng IO
PLoS One; 2008 Jul; 3(7):e2779. PubMed ID: 18648664
[TBL] [Abstract][Full Text] [Related]
17. Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells.
Shih YP; Takada Y; Lo SH
Mol Cancer Res; 2012 Jan; 10(1):34-9. PubMed ID: 22064653
[TBL] [Abstract][Full Text] [Related]
18. START-GAP2/DLC2 is localized in focal adhesions via its N-terminal region.
Kawai K; Seike J; Iino T; Kiyota M; Iwamae Y; Nishitani H; Yagisawa H
Biochem Biophys Res Commun; 2009 Mar; 380(4):736-41. PubMed ID: 19250640
[TBL] [Abstract][Full Text] [Related]
19. Integrin dynamics and matrix assembly: tensin-dependent translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis.
Pankov R; Cukierman E; Katz BZ; Matsumoto K; Lin DC; Lin S; Hahn C; Yamada KM
J Cell Biol; 2000 Mar; 148(5):1075-90. PubMed ID: 10704455
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.
Chen L; Liu C; Ko FC; Xu N; Ng IO; Yam JW; Zhu G
J Biol Chem; 2012 Jul; 287(31):26104-14. PubMed ID: 22645138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
